Detalles de la búsqueda
1.
Comparison of MAPIE versus MAP in patients with a poor response to preoperative chemotherapy for newly diagnosed high-grade osteosarcoma (EURAMOS-1): an open-label, international, randomised controlled trial.
Lancet Oncol
; 17(10): 1396-1408, 2016 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-27569442
2.
Intensified Chemotherapy With Dexrazoxane Cardioprotection in Newly Diagnosed Nonmetastatic Osteosarcoma: A Report From the Children's Oncology Group.
Pediatr Blood Cancer
; 63(1): 54-61, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26398490
3.
Analysis of serum insulin growth factor-1 concentrations in localized osteosarcoma: a children's oncology group study.
Pediatr Blood Cancer
; 61(4): 749-52, 2014 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-24178953
4.
Ototoxicity in children treated for osteosarcoma.
Pediatr Blood Cancer
; 52(3): 387-91, 2009 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-19061216
5.
Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate.
J Clin Oncol
; 23(9): 2004-11, 2005 Mar 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-15774791
6.
Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651.
J Clin Oncol
; 21(8): 1574-80, 2003 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12697883
7.
Phase II/III trial of etoposide and high-dose ifosfamide in newly diagnosed metastatic osteosarcoma: a pediatric oncology group trial.
J Clin Oncol
; 20(2): 426-33, 2002 Jan 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-11786570
8.
Methotrexate, Doxorubicin, and Cisplatin (MAP) Plus Maintenance Pegylated Interferon Alfa-2b Versus MAP Alone in Patients With Resectable High-Grade Osteosarcoma and Good Histologic Response to Preoperative MAP: First Results of the EURAMOS-1 Good Response Randomized Controlled Trial.
J Clin Oncol
; 33(20): 2279-87, 2015 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-26033801
9.
Phase II trial of trastuzumab in combination with cytotoxic chemotherapy for treatment of metastatic osteosarcoma with human epidermal growth factor receptor 2 overexpression: a report from the children's oncology group.
J Clin Oncol
; 30(20): 2545-51, 2012 Jul 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22665540
10.
Inhaled granulocyte-macrophage colony stimulating factor for first pulmonary recurrence of osteosarcoma: effects on disease-free survival and immunomodulation. a report from the Children's Oncology Group.
Clin Cancer Res
; 16(15): 4024-30, 2010 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20576718
11.
Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study.
J Clin Oncol
; 27(15): 2536-41, 2009 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-19349548
12.
Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
J Clin Oncol
; 26(4): 633-8, 2008 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18235123
13.
Multiple drug resistance in osteogenic sarcoma: INT0133 from the Children's Oncology Group.
J Clin Oncol
; 25(15): 2057-62, 2007 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-17513810
14.
Intensive therapy with growth factor support for patients with Ewing tumor metastatic at diagnosis: Pediatric Oncology Group/Children's Cancer Group Phase II Study 9457--a report from the Children's Oncology Group.
J Clin Oncol
; 24(1): 152-9, 2006 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-16382125
15.
Phase II study of ecteinascidin 743 in heavily pretreated patients with recurrent osteosarcoma.
Cancer
; 98(4): 832-40, 2003 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-12910529
16.
Ovarian toxicity after chemotherapy: possible association with ifosfamide administration.
Pediatr Blood Cancer
; 42(3): 216-9, 2004 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-14752857
Resultados
1 -
16
de 16
1
Próxima >
>>